Pfizer Inc. Chief Executive Officer Ian Read refused to be pinned down on his commitment to preserve jobs in the U.K. as skeptical lawmakers grilled him about the company’s unsolicited offer for AstraZeneca Plc.
After a rough ride in front of the U.K. Parliament’s Business Committee yesterday, Pfizer Inc. Chief Executive Officer Ian Read got gentler treatment from its science and technology panel today over his plan to take over AstraZeneca Plc.
Pfizer Inc. Chief Executive Officer Ian Read fought back against accusations that his bid for AstraZeneca Plc would harm patients and damage science in the U.K. as he faced Parliament for a second day.
Pfizer Inc., the U.S. drugmaker seeking to acquire AstraZeneca Plc, advanced its U.K. charm offensive with a series of videos extolling the scientific benefits, while downplaying the potential tax advantages.
Pfizer Inc. Chief Executive Officer Ian Read faces heightened public scrutiny of his bid for AstraZeneca Plc this week when he’ll be questioned by lawmakers on his commitment to the U.K. in hearings broadcast live.